From Congress to Clinic: A Post-JSMO Update on Novel Antibody–Drug Conjugates and Other Agents Targeting HER3 in NSCLC

Watch a CME-certified webcast and download the slides from a live, expert-led webinar to learn about new agents targeting HER3 for the treatment of non-small-cell lung cancer, including review of recent data reported at JSMO 2023.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.